J Korean Surg Soc.  2000 Jun;58(6):824-833.

Prospective Clinical Study of Prophylactic Antibiotic Therapy in Nonperforated Appendicitis

Affiliations
  • 1Department of Pharmacy and General Surgery, Kangnam General Hospital Public Corporation.
  • 2Department of Surgery, College of Medicine, Gangwon National University.

Abstract

PURPOSE: Prophylactic antibiotics have been used in nonperforated appendicitis for preventing infection after an appendectomy. However, the duration of antibiotic administration for surgical prophylaxis in Korea has been noted to be longer than those recommended in other countries. PURPOSE: The objective of this study was to identify the appropriate duration of prophylactic antibiotic therapy in nonperforated appendicitis by comparing the wound infection rates of two different antibiotic regimens, 24 hours of cephalosporin (cefoxitin) alone and 72 hours of cephalosporin (cefoxitin) with aminoglycoside (sissomicin). METHODS: One hundred thirty-four (134) patients of nonperforated appendicitis were enrolled in this prospective, randomized, open trial and were assigned to one of two antibiotic regimens: 1) cefoxitin 1 g every 8 hours given intravenously for 24 hours and 2) cefoxitin 1 g every 8 hours given intravenously plus sissomicin 75 mg every 12 hours given intramuscularly for 72 hours. First doses were given just prior to the induction of anesthesia. RESULTS: Postoperative wound infections were detected in 3 cases (4.5%) of the 72-hour-treated group (n=66) whereas none occurred in the 24-hour-treated group (n=68). However, the difference in the rates of wound infections between the two groups was not statistically significant. Cost analysis identified a saving of 43,470 won per patient in the 24-hour-treated group. CONCLUSION: In nonperforated appendicitis cefoxitin administration alone for 24 hours is sufficient as a surgical prophylaxis.

Keyword

Duration; Prophylactic antibiotics; Appendicitis; Infection rates

MeSH Terms

Anesthesia
Anti-Bacterial Agents
Appendectomy
Appendicitis*
Cefoxitin
Costs and Cost Analysis
Humans
Korea
Prospective Studies*
Sisomicin
Surgical Wound Infection
Wound Infection
Anti-Bacterial Agents
Cefoxitin
Sisomicin
Full Text Links
  • JKSS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr